These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19939577)

  • 41. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
    Yoo S; Wu QJ; Lee WR; Yin FF
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.
    Fischer-Valuck BW; Chundury A; Gay H; Bosch W; Michalski J
    Pract Radiat Oncol; 2017; 7(3):195-202. PubMed ID: 28089528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maximizing rectal dose sparing with hydrogel: A retrospective planning study.
    Paetkau O; Gagne IM; Pai HH; Lam J; Goulart J; Alexander A
    J Appl Clin Med Phys; 2019 Apr; 20(4):91-98. PubMed ID: 30889318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.
    Wu SY; Boreta L; Wu A; Cheung JP; Cunha JAM; Shinohara K; Chang AJ
    Brachytherapy; 2018; 17(2):259-264. PubMed ID: 29203149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
    Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy.
    Chao M; Ho H; Chan Y; Tan A; Pham T; Bolton D; Troy A; Temelcos C; Sengupta S; McMillan K; Cham CW; Liu M; Ding W; Subramanian B; Wasiak J; Lim Joon D; Spencer S; Lawrentschuk N
    BJU Int; 2018 Sep; 122(3):427-433. PubMed ID: 29520983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency.
    Wolf F; Gaisberger C; Ziegler I; Krenn E; Scherer P; Hruby S; Schätz T; Forstner R; Holzinger J; Vaszi A; Kametriser G; Steininger P; Deutschmann H; Sedlmayer F
    Radiother Oncol; 2015 Aug; 116(2):221-5. PubMed ID: 26232129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
    Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer.
    Munbodh R; Jackson A; Bauer J; Schmidtlein CR; Zelefsky MJ
    Med Phys; 2008 May; 35(5):2137-50. PubMed ID: 18561689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancer.
    Gluck I; Vineberg KA; Ten Haken RK; Sandler HM
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):334-40. PubMed ID: 19147014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
    J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rectal wall sparing effect of a rectal retractor in prostate intensity-modulated radiotherapy.
    Ghaffari H; Rostami A; Ardekani MA; Mofid B; Mahdavi SR
    J Cancer Res Ther; 2021; 17(2):383-388. PubMed ID: 34121681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
    Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate.
    Guckenberger M; Pohl F; Baier K; Meyer J; Koelbl O; Flentje M; Vordermark D
    Strahlenther Onkol; 2006 Dec; 182(12):721-6. PubMed ID: 17149579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rectal sparing in prostate radiotherapy with combination-brachytherapy and hydrogel spacer.
    Cousins MM; Heckman P; Short E; Narayana V; Bryant AK; Evans C; Hixson G; Hurley P; McLaughlin PW
    Brachytherapy; 2022; 21(3):300-307. PubMed ID: 35125329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose-escalated prostate cancer radiotherapy.
    van Gysen K; Kneebone A; Alfieri F; Guo L; Eade T
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):511-6. PubMed ID: 24580893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
    Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
    Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
    O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
    Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.